Clinical trials
Observational Respiratory Insufficiency trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
97 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 8 |
| 2018 | 9 |
| 2019 | 11 |
| 2020 | 12 |
| 2021 | 7 |
| 2022 | 6 |
| 2023 | 9 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 97 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Taiwan University Hospital | 4 |
| Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche | 3 |
| Massachusetts General Hospital | 3 |
| Erasme University Hospital | 2 |
| Poitiers University Hospital | 2 |
| Southeast University, China | 2 |
| Unity Health Toronto | 2 |
| University Health Network, Toronto | 2 |
| University Hospital, Strasbourg, France | 2 |
| University of Colorado, Denver | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Insufficiency | 97 |
| COVID-19 | 14 |
| Respiratory Distress Syndrome | 7 |
| Critical Illness | 5 |
| Respiratory Aspiration | 5 |
| Pneumonia | 4 |
| Pulmonary Disease, Chronic Obstructive | 4 |
| Sepsis | 4 |
| Shock | 4 |
| Delirium | 3 |
Trials
Showing 1 to 25 of 97. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.